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Abstract
The crystal structure of rhodopsin has provided the first three-dimensional molecular model for a G-protein-coupled receptor (GPCR).
Alignment of the molecular model from the crystallographic structure with the helical axes seen in cryo-electron microscopic (cryo-EM)
studies provides an opportunity to investigate the properties of the molecule as a function of orientation and location within the membrane. In
addition, the structure provides a starting point for modeling and rational experimental approaches of the cone pigments, the GPCRs in cone
cells responsible for color vision. Homology models of the cone pigments provide a means of understanding the roles of amino acid sequence
differences that shift the absorption maximum of the retinal chromophore in the environments of different opsins.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Rhodopsin is a G-protein-coupled receptor (GPCR) that
responds to environmental signals, i.e., photons, and ini-
tiates intracellular processes that eventually result in an
electrical signal processed by the visual system [1–4].
Rhodopsin is an integral membrane protein located in the
outer segments of rod photoreceptor cells in the retina
[5,6]. Retinas of animals with vision systems capable of
wavelength differentiation, i.e., color vision, contain cone
cells, the outer segments of which contain opsins as their
photoreceptor proteins [7]. Cone opsins have amino acid
sequences similar to that of rhodopsin, but with specific
differences that affect the wavelength sensitivity of the
receptor [8–11].
All opsins contain a retinylidene cofactor covalently
bound to the protein via a Schiff-base linkage to a lysine
side chain. Absorption of light by the retinal causes a cis–
trans isomerization of the cofactor. This is followed by a
conformational change in the protein that allows binding of
a G-protein (transducin) to the cytoplasmic surface of the
receptor [12–16]. Rhodopsin is one of the most extensively
studied GPCRs. It can be isolated from retina from a number
of species. Bovine eyes are readily available from meat
packing plants and are a major source of rhodopsin. The
presence of the polyene chromophore aids in characterizing
and assaying for the protein.
As in the case of other GPCRs, rhodopsin folds into a
compact tertiary structure containing seven trans-mem-
brane helices [17]. In most cases, GPCRs are located in
membrane bilayers with one surface oriented towards the
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cytoplasm of the cell and one towards the extracellular
environment. The outer segments of rod cells contain
stacks of flattened disks, each of which is a cellular
compartment enclosed by a bilayer membrane [7]. Most
of the rhodopsin in rod cells is located in these bilayers.
Topologically, the intradiscal spaces are equivalent to the
extracellular environment sampled by other GPCRs.
GPCRs are a large class of membrane proteins
involved in a number of clinically important ligand/
receptor processes [18–22]. Accordingly, these proteins
are significant drug targets. In most cases, the agonist for
these receptors is a small molecule ligand. In the case of
rhodopsin, the agonist is the retinal chromophore and a
photon. Many GPCRs bind hydrophobic ligands, and
comparative studies indicate that the retinal-binding site
is similar to the ligand binding sites in other GPCRs
[22,23].
The importance of these molecules makes them ob-
vious targets for structural studies, and a number of
biophysical techniques have been applied to obtain struc-
tural information [12,22,23]. While the seven trans-mem-
brane helices could be inferred from sequence analyses
and comparisons with bacteriorhodopsin, cryo-electron
microscopy (cryo-EM) investigations of rhodopsin pro-
vided the first experimental evidence for the seven
helices in these molecules [24,25]. A number of spectro-
scopic techniques have characterized the photostates of
the molecule [26,27] and probed the dynamics of the
protein as the chromophore and protein conformations
change. Spin-label studies have been especially powerful
in determining what parts of the structure change in
response to photon absorption [28–30]. Also, NMR
studies of rhodopsin peptides have characterized the
secondary structure of segments of the protein [31], and
NMR studies of the complete protein have also been
reported [32].
2. Summary of structure determination
Last year, the crystal structure of bovine rhodopsin
was obtained at 2.8 A˚ resolution [33]. A post-doctoral
fellow, Dr. T. Okada, developed an efficient protocol for
purifying the protein from natural sources [34,35]. The
method involves the solubilization of the protein in nonyl
glucoside in the presence of 80 mM Zn2 +. Under these
conditions, other proteins, including bleached rhodopsin
and opsin, become insoluble with time and are removed
by centrifugation. SDS-PAGE and Western blots of the
pellet showed opsin bands. Western blots also identified
Fig. 1. Stereoviews of rhodopsin. (A) In the orientation favored by vision
scientists with the cytosolic surface oriented upwards. (B) In the orientation
favored by for other GPCRs with the cytosolic surface facing downwards.
In both orientations, the retinal chromophore is shown as a ball-and-stick
figure (black) inside the protein. Vertical axis parallel to the membrane
normal. Figures drawn with Molscript [55].
Fig. 2. Stereoview of the kink in helix I. The presence of the proline ring at
position 53 and the lack of a hydrogen bond donor for that residue disrupts
the structure of the alpha helix. The carbonyl of Met-49 is crowded out of
the normal conformation for alpha helical residues. The rest of the helix
(beyond Pro-53) bends to accommodate the packing of the proline side
chain and this introduces a kink in the helical axis. Figures drawn with
Molscript [55].
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ion channels, peripherin, ROM, guanylate cyclase and a
dehydrogenase. Vapor diffusion crystallization techniques,
using ammonium sulfate as the precipitant, yielded dif-
fraction quality crystals [34]. Heptane-1,2,3-triol was used
as an additive for crystallization. The crystals were
merohedrally twinned and sensitive to visible light. The
twinning complicated identification of the correct space
group and the initial attempts to solve the structure.
Bleaching of the crystals (and concomitant destruction
of the diffraction pattern) forced the collection of dif-
fraction data under low levels of red light. Attempts to
solve the structure using bacteriorhodopsin as a molecular
replacement model failed, so heavy metal derivatives of
the natural protein were generated for MIR and MAD
phasing experiments. Initial diffraction data for the native
protein as well as mercury derivatives were collected at
the SSRL and APS synchrotrons, but the structure was
solved using a six wavelength mercury MAD data set
obtained at SPring8 on a crystal with a 10% twinning
ratio. Crystallographic refinement of the two molecules in
the asymmetric unit was fairly straightforward [33,36].
3. Protein structure
Fig. 1 shows the resulting structure of rhodopsin with
the seven transmembrane helices and the extracellular and
cytosolic loops. Fig. 1A shows the molecule in the
orientation most familiar to vision scientists with the
cytosolic surface facing upwards. Fig. 1B displays the
structure in the orientation favored by the GPCR com-
munity; extracellular face upwards. The seven transmem-
brane helices are labeled I through VII, and they span the
membrane with the same overall topology as found in
bacteriorhodopsin. Helix VIII is a short helix connected
directly to helix VII that lies with its helical axis parallel
to the membrane surface. The helix most likely does not
penetrate deeply into the hydrophobic region of the
membrane.
The seven transmembrane helices in rhodopsin are not
regular a-helices. The kinks and twists in the helices
have been analyzed [37] and in some cases have been
associated with elements of 310 or k helix. In helices I,
IV, V, VI and VII, the bends are associated with proline
residues. Fig. 2 shows the kink in helix I involving Pro-
53. While the proline side chain removes the main chain
hydrogen bond for this residue, its phi and psi conforma-
tional angles are close to those found in a-helices (phi =
 49j, psi = 51j in molecule A of Protein Data Bank
(PDB) [38] entry 1HZX). The carbonyl of Met-49 would
normally make a hydrogen bond to the amide of residue
53, but in this case, it twists away from the helical axis
due to close contacts with the proline side chain. The psi
angle of Met-49 twists to a slightly lower negative value
Fig. 3. (A) Stereoview of the rhodopsin structure from the three-
dimensional crystals (ribbons) (PDB ident 1HZX) superposed on the
helical axes from the two-dimensional cryo-EM study (black rods) [40].
Vertical axis parallel to membrane normal. (B) Stereoview of helices VI and
VII after rotation by 90j about the vertical axis. Figures are drawn with
Molscript [55].
Fig. 4. Stereoview of the backbone tracing of rhodopsin showing the
locations of the tryptophan side chains (black ball-and-stick representation).
Vertical axis parallel to the membrane normal. Figures are drawn with
Molscript [55].
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than found in alpha helices,  24j, and the phi angle of
Leu-50 moves to  112j. The major conformational
changes in the helical residues associated with the inclu-
sion of the proline in the helix occur at residues located
one turn towards the N-terminus from the proline.
This same pattern of conformational adjustments occurs
at the kink in helix V and the two kinks in helix VII. The
bend in helix IV is similar, but it is complicated by the
presence of two prolines adjacent to each other in the
polypeptide, Pro-170 and Pro-171, and their location near
the C-terminal end of the helix. Several more of the residues
near the prolines are involved in accommodating the per-
turbation of the helix by the imino acids.
Helix VI shows the same pattern of conformational
adjustments connected with Pro-267, but for this helix, the
adjustments in phi and psi occur at residues two and three
positions before the proline (Trp-265 and Cys-264). This
has the effect of tightening the next turn of the helix, which
moves the proline side chain relative to the carbonyl of
residue 264 (its normal partner in an alpha helix) and
alleviates the close packing of the atoms.
The kink in helix II is not associated with a proline.
The helix contains a pair of glycine residues at positions
89 and 90. The helix at this point bulges slightly and
accommodates one extra residue with the net effect of
introducing a bend in the helix. The phi angle for Gly-90
is  98j. Phe-83 has a phi angle of  83j, and Phe-91
has a smaller than normal psi angle. A more obvious
feature of the distortion is the disruption in the hydrogen
bonding pattern that comes with the extra residue. The
carbonyl groups of residues 88 and 89 no longer make
hydrogen bonds within the helix backbone, nor does the
amide of residue 90. It is not obvious what causes these
residues to deviate from the normal alpha helical con-
formation, but it seems likely that the lack of side chain
atoms for the glycine residues allows this sort of helix
bend.
All of the extracellular loops are visible in our
electron density maps, so the molecular model is com-
plete for this surface. Two glycosylation sites are located
on this face of the molecule and 11 sugar residues have
been added to the model based on the electron density.
Two short beta strands are also located on this side of the
Fig. 5. Stereoview of the backbone tracing of rhodopsin showing the
distribution of charged side chains in the molecule. The two horizontal lines
denote the surfaces of the membrane bilayer. Vertical axis is parallel to the
membrane normal. Figure are drawn with Molscript [55].
Fig. 6. The molecular surface of rhodopsin in orthogonal views. That part of the surface marking the edges of the membrane bilayer is shown in blue.
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Fig. 7. Distribution of residue types along the direction of the membrane normal. Horizontal scale in angstroms starting on the extracellular side of the protein.
The origin on the horizontal scale is taken from the cryo-EM structure [40]. Vertical lines denote margins of the bilayer membrane as identified in Fig. 5.
Distributions of: (A) Polar side chains; (B) non-polar side chains; (C) aromatic side chains; (D) non-aromatic, non-polar side chains; (E) charged side chains;
(F) uncharged, polar side chains.
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transmembrane helices and form a ‘‘plug’’ [39] that limits
accessibility to the chromophore site from this surface.
The cytosolic face of the protein is not as well
characterized due to static or dynamic disorder of cyto-
plasmic loop II and the C-terminal tail of the protein.
This might be due to defects in the crystal packing in
this region, but it is more likely associated with the
dynamics of binding of the G-protein to this surface, see
below.
4. Comparison with frog rhodopsin
Prior to the crystal structure analysis, cryo-EM studies
of frog rhodopsin [25] provided the most detailed view of
the molecule. Subsequently, the same group published a
low-resolution electron density map showing the arrange-
ment of the seven transmembrane helices in the molecule
[40]. Coordinates of the helical axes can be extracted from
that map, and Fig. 3A shows the superposition of the
molecular model obtained from the three-dimensional
crystals on those helical axes. The two structures super-
pose fairly well and indicate that both structure analyses
are free of large experimental or computational artifacts.
The structures we are observing are compact, ordered
protein structures with seven helices closely packed
together.
Cryo-EM and crystallographic techniques show that
helix VI is kinked, but they give conflicting views of
helix VII. In the bovine rhodopsin structure seen in the
three-dimensional crystals, the helix is quite bent and
irregular, but in the low resolution structure obtained
Fig. 8. Distribution of accessible surface area along the direction of the membrane normal. The areas are classified according to the type of atom associated with
them. Horizontal axis as in Fig. 7.
Fig. 9. Average temperature factors along the direction of the membrane normal. Horizontal axis as in Fig. 7.
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from two-dimensional crystals, it was interpreted as a
straight helix (see Fig. 3B). This modeling difference
might be due to the difficulties of interpreting low-
resolution electron density maps, or it might be due to
chemical differences (photostates) between the frog and
bovine rhodopsin preparations.
5. Rhodopsin orientation in the membrane
In addition to confirming the basic structures seen in
the two studies, superposition of the bovine rhodopsin
structure with that of frog rhodopsin provides the best
method for seeing how the molecule is oriented in the
membrane. In the cryo-EM study, the z-axis of the
electron density map is perpendicular to the membrane.
In the three-dimensional crystal structure, the two mole-
cules in the asymmetric unit are not oriented in any
special direction that gives any information about the
alignment of the protein in the membrane. In addition,
no intramolecular features provide strong evidence for the
location and orientation of the membrane relative to the
protein. Thus, alignment of the higher resolution model
with the frog rhodopsin helices is the most powerful
method for connecting the crystal structure with that in
the membrane.
Analyses of amino acid distributions in previous
membrane proteins showed that tryptophan side chains
are often located at the interface between the bilayers and
the aqueous environment [41]. For rhodopsin, that is not
the case (see Fig. 4). Only one of the five tryptophans is
located near where the protein surface changes from
being hydrophobic to being hydrophilic. The other tryp-
tophans are involved in packing interactions between the
helices or with the hydrophobic region of the membrane.
Fig. 5 shows the location of charged side chains in
rhodopsin. These residues more clearly delimit the hydro-
philic and hydrophobic surfaces of the protein. Planes
that would exclude most of the charged side chains
would be about 30 A˚ apart. The location of the mem-
brane surfaces is also shown in Fig. 6. This is a
reasonable estimate for the membrane thickness, espe-
cially since local expansion or contraction of the mem-
brane thickness near the protein is possible. It is
interesting that the upper delimiting plane in Fig. 5 lies
just at the lower surface of helix VIII. There are a few
charged groups between the delimiting planes, notably
Lys-296 (site of attachment of the chromophore) and
Glu-113 (counterion for the protonated Schiff base). Most
of the other internal charged side chains are involved in
hydrogen-bonding interactions within the protein, but the
side chain of Asp-83 appears to be only weakly involved
in those interactions.
Some of the other residue types in rhodopsin are also
asymmetrically distributed along the membrane normal.
Fig. 7 shows the distribution of residue types. The
distributions are as one would expect for a membrane
protein. The charged and polar groups tend to be located
outside the hydrophobic part of the protein spanning the
membrane. Hydrophobic groups, however, are found in
the loops between the transmembrane helices as well as
along the helices. There is a slight partitioning of the
aromatic groups in the protein with more of them
associated with the extracellular side of the molecule.
Fig. 10. Stereoviews of the retinal binding site. (A) View of binding site with residues covering the retinal removed. (B) View of binding site after rotation by
180j about the vertical axis. Selected residue numbers are included. Figure drawn with Molscript [55] and Raster3d [56].
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This is not reflected in the overall distribution of hydro-
phobic groups, so the distribution of smaller aliphatic
side chains must be shifted to the cytoplasmic side.
Perhaps this is associated with the structural flexibility
and conformational changes that take place on the cyto-
plasmic surface in the interactions with G proteins.
Fig. 8 shows the accessible surface along the normal to
the membrane plane. The extracellular side is at the negative
z-axis while the cytoplasmic side is at the positive z-axis on
the histogram. Three accessible surfaces are plotted: (1)
charged atoms, (2) charged and polar atoms, and (3)
charged, polar and nonpolar atoms. The last measurement
Fig. 11. Two-dimensional models of (A) rhodopsin, (B) blue opsin, (C) green opsin, and (D) red opsin. The transmembrane topology was originally
schematically represented by Nathans [57], but it is now improved based on the rhodopsin crystal structure [33]. Key residues are shown in filled circles, while
residues not modeled in the rhodopsin crystal structure are marked in grey. Glycosylation sites are denoted by small branched chains on the extracellular side of
the protein. Palmitoyl groups are also included near residue 320 for rhodopsin and blue opsin. The extracellular loops are denoted E-I, E-II and E-III. The
cytoplasmic loops are C-I, C-II and C-III.
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is the total accessible surface for each 1 A˚ slice. Static
accessibility [42] was measured by the method of Shrake
and Rupley [43] using the van der Waals radii of Chothia
[44].
On the extracellular side of the membrane center, two
charged atoms, Glu-201 OE1 and OE2, are accessible to the
1.4 A˚ probe. This residue is located in the N-terminal region
of helix V and nearby electron density has been assigned to
a Zn atom with occupancy of 0.5. In the membrane assign-
ment of Teller et al. [36], the residue was placed on the edge
of the transmembrane domain, which was postulated to
begin at residue 200 in this helix. This residue’s alpha
carbon position is about 1 A˚ from what was considered to
be the outer edge of the transmembrane domain.
Glu-232 and Arg-252 are the charged residues appearing
at 17–20 A˚ on the z-axis coordinate of Fig. 8. Glu-232 is a
Fig. 12. Two-dimensional models showing amino acid differences between (A) blue opsin and rhodopsin, (B) green opsin and rhodopsin, (C) red opsin and
rhodopsin, and (D) green opsin and red opsin. Open circles are identical amino acids in both pigments, while filled circles denote the locations of amino acid
differences. The overall homology between the blue, green and red cone pigments versus rhodopsin is 41%, 38% and 37%, respectively.
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part of cytoplasmic loop C-III and Arg-252 is located in the
N-terminal region of helix VI. These residues are 4 and 6 A˚
from the inner limit of the transmembrane domain as
determined by Teller et al. [36]. The charged portions of
these two residues may form a salt bridge, but the position
of Glu-232 is uncertain (B factor = 117 A˚2 for its alpha
carbon atom). From the coordinates, it looks as if Glu-232
could form a hydrogen bond either with the Arg-252
guanido group or with the Tyr-223 OH by rotation of some
chi angles. In the current coordinate set, the guanidinium
group of Arg-252 forms a hydrogen bond to O5 of h-
nonylglucoside 1501.
The profile of accessible surface of charged and polar
atoms resembles the probability density profiles of charged
plus polar atoms in the liquid crystallographic structure of a
fluid lipid bilayer [45,46]. In the region from Z = 10 to
+ 16, the accessibility is almost exclusively at nonpolar
atoms.
The distribution of average temperature factors along the
helix normal is also as expected, see Fig. 9. The center of
the molecule is more rigid than the parts outside the
membrane. The disorder and flexibility of the cytoplasmic
loops and C-terminal tail are consistent with the higher B
values on this side of the protein.
6. Retinal binding site
Fig. 10 shows the retinal binding site in rhodopsin.
Residues with side chain or main chain atoms within 5 A˚
are shown in the figure. The chromophore binding site is
largely hydrophobic, as would be expected for an environ-
ment favorable for a polyene chromophore. Two phenyl-
alanine residues (Phe-212 and Phe-261) are near the ionone
ring of the retinal, but Glu-122 also is close to the ring. The
side chain of Trp-265 is located near the center of the
binding site, and the retinal bends around it in its ground
state conformation. Other polar groups near the central part
of the polyene are Thr-118 and Tyr-268. Glu-113 is found
near the Schiff-base linkage between retinal and Lys-296
Fig. 13. Superimposition of blue cone pigments and bovine rhodopsin (white). Only major differences between structures are shown for clarity of the picture.
(A) Blue cone pigment (in blue). (B) Red and green (the same backbone shown in red). The arrow indicates the location of an additional peptide loop in red and
green opsins.
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where it can serve as a counterion when the Schiff base is
protonated (Fig. 10).
Regeneration of ground state rhodopsin after activation
of the protein is associated with removal of the chromo-
phore from the protein, formation of the cis-isomer, and
reinsertion of the cis-conformer into the protein. The crystal
structure of the ground state provides no evidence for how
the chromophore gains access to the binding site. The site is
completely buried and is inaccessible from outside the
protein. Accessible surface calculations with smaller probe
sizes than the normal 1.4 A˚ water probe indicate that slight
movements of several of the helices would permit access to
the site from the hydrophobic center of the bilayer. The
binding site accommodates various retinals and their con-
formations (for recent studies, see Refs. [47,48]).
7. Cone opsins
Cone cells contain photoreceptor proteins related to
rhodopsin, but with variations in the residues neighboring
the retinal chromophore. The amino acid sequences of the
human blue, red and green cone pigments, along with that
of bovine rhodopsin, are shown in Fig. 11, superposed on
their presumed secondary structure. The amino acid
sequence identities for the blue, green and red cone pig-
ments with rhodopsin are 41%, 38% and 37%, respec-
tively. These are shown as differences in Fig. 12. Some of
the differences in the amino acid sequences are associated
with an altered environment for the chromophore that
gives rise to shifts in its absorption spectrum and the
wavelength dependence of the receptor’s response. Homol-
ogy modeling of the cone pigments based on the rhodopsin
structure provides one means of understanding the molec-
ular basis of color vision.
Theoretical models of cone pigments were constructed
with the homology modeling program Modeler [49,50] in
the InsightII package. Modeler is a program designed to find
the most probable three-dimensional structure of a protein,
given its amino acid sequence and its alignment with related
structures. The related or reference protein structures are
used to derive spatial restraints expressed as probability
density functions for each of the restrained features of the
model. The individual restraints are assembled into a single
molecular probability density function. The 3D protein
model is then obtained by an optimization of this probability
function. We have used the structure of bovine rhodopsin,
1HZX [36] as a template. To obtain proper alignment of the
cone pigment sequences with rhodopsin, we used additional
sequences of different GPCR proteins. Limited use was
made of the homology-modeling program’s restrained simu-
lated annealing molecular dynamics scheme because it was
Fig. 14. Surface of cone pigments. Colors denote partial charges of surface atoms. (A) Blue cone pigment. (B) Green (red is very similar). The arrow denotes
the location of the additional loop as in Fig. 13. These homology models for the cone pigments have been deposited in the PDB (identifiers 1KPN, 1KPW,
1KPX).
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designed for modeling globular proteins while the cone
pigments are integral membrane proteins.
To verify whether amino acid sequences of the cone
pigments are compatible with the model structure, we used
the Profiles-3D program [51] from the InsightII package.
The program measures the compatibility of an amino acid
sequence with a three-dimensional structure by reducing
the structure to a one-dimensional representation, known as
a 3D profile, which can be aligned with the sequence.
After the homology models were obtained, retinal was
inserted into the central cavity and covalently linked to the
relevant lysine. The structures of the cone pigments were
Fig. 15. Vicinity of retinal in cone pigments. Charged amino acids are indicated in red. (A) Blue cone pigment. (B) Green. (C) Red.
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subjected to a small degree of optimization confined to a
volume within 5 A˚ of the retinal and covalently linked
lysine.
Since the sequences of the cone pigments are closely
related to that of rhodopsin, the entire transmembrane region
has neither insertions nor deletions in the cone pigment
sequences that assist in the homology modeling. Modeler
does not require so-called ‘‘structurally conserved regions’’,
but instead, it uses all of the sequence and structure
information to construct a probability density function.
The resulting structures are shown in Fig. 13A for blue
and Fig. 13B for red and green cone pigments. Only the
major differences between the cone pigments and the
template bovine rhodopsin are shown. They are located in
the N- and C-terminal regions of the structure. For red and
green cone pigments, there is an additional loop of 10 amino
acids (indicated with an arrow in Fig. 13B) close to the N-
terminal. This loop nicely fits into the rest of the structure so
nearly half of the loop is hidden. The sequence alignment of
the red and green cone pigments goes beyond the N-
terminal so these parts were modeled to maximize inter-
actions with the N-terminal loop. Verification scores from
the Profiles-3D program for the models are 103 (red cone
pigment) and 106 (green cone pigment). For comparison,
the score of bovine rhodopsin 1HZX is 112. For the blue
cone pigment, the score is 93. For a protein of this size, a
score of 71 or less would indicate a structure that is almost
certainly incorrect. These homology models for the cone
pigments have been deposited in the PDB (identifiers
1KPN, 1KPW and 1KPX for the blue, green and red cone
pigments, respectively).
The secondary structure of all three cone pigments is
nearly identical with that of rhodopsin and exhibits seven
transmembrane helices, one cytoplasmic helix and two beta
strands. The only difference (the same for all cone types) is
the extension of the N-terminal beta-strand by one amino
acid compared to bovine rhodopsin (results not shown). The
surfaces of the cone pigments are similar to the bovine
rhodopsin surface (Fig. 14). The partial charges of the
surface atoms in the transmembrane domain are close to
zero (white color). The cytoplasmic and extracellular
domains of the cone pigments contain nearly all the partial
charges found on the surface. An arrow denotes, as pre-
viously, the additional loop in green and red cone pigments.
Retinal was excluded from the homology modeling
process and inserted after the models were built. The
vicinity of the retinal in the modeled cone pigments is
shown in Fig. 15. As in bovine rhodopsin, the environment
around the retinal in all three cone pigments is strongly
hydrophobic. Red and green cone pigments share nearly the
same sequence so their retinal sites are nearly identical. The
central residue forming the cavity is Trp-281 (analogous to
Trp-265 in bovine rhodopsin). The counterion to the Schiff
base is also glutamic acid, Glu-129 (113 in bovine rhodop-
sin). There is also another glutamic acid, Glu-102, located
near Lys-312, the lysine covalently linked to the retinal. The
second glutamic acid probably influences the spectrum by
causing a red shift by increasing the negative electron
density of the first glutamic acid and hence diminishing
the positive charge distribution over the conjugated bonds of
retinal. Delocalization of the electrons along the polyene
chain is complex and involves stabilization by charged
groups including the two glutamates [52,53].
Contrary to other cone pigments, the central residue
forming the cavity in blue cone pigments is Tyr-262.
Because of the proximity of the retinal beta-ionone ring,
Tyr-262 is the major factor in the blue shift of this pigment.
The second glutamic acid present in red and green cone
pigments is absent in this protein, and this causes an
additional blue shift. There are additional residues close
to the counterion in all three cone pigments. Ser-183 forms
a hydrogen bond with Glu-110 in blue cone pigments (Fig.
16). In green and red cone pigments, there are two serines,
110 and 202, that are able to form a hydrogen bond to the
counterion. Whether a hydrogen bond is formed depends on
the free energy of this reaction. This is difficult to calculate
for such large systems. The existence of chloride ion bind-
ing sites in green and red opsins has been postulated [54],
and two residues, His and Lys, are believed to be involved
in the site. Such a modeled site is shown in Fig. 17. The
positive charges of His-197 and additionally Tyr-284 and
Ser-202 (and positive charge on the retinal chain) can
stabilize Cl. In our model, Lys-200 is too far away from
the site to interact with Cl. These differences between our
Fig. 16. Influence of Ser-183 on Schiff base interactions in the blue cone
pigment.
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model and the postulated site [54] could be a result of a
long distance effect of the Lys mutants on Cl coordination,
or the local conformation in this region in our model is not
correct. These differences will need to be resolved by
further experiments. It is important to mention that these
two residues, His and Lys, are strictly conserved in all long-
wavelength cone pigments but are absent in all rhodopsins
and short-wavelength pigments. The models of the cone
pigments contain neither water molecules nor inorganic
ions. The influence of these on the spectra is highly
dependent on where they are positioned inside the structure
and the number of hydrogen bonds they form. Additional
calculations are required to elucidate their role in spectral
tuning.
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